生命科學領域人工智慧市場：按產品、分析方法、應用、最終用戶、實行技術、分銷管道和區域分類

預計到 2025 年，生命科學領域的人工智慧市場規模將達到 37.3 億美元，到 2032 年將達到 180.9 億美元，2025 年至 2032 年的複合年成長率為 25.3%。

全球生命科學人工智慧市場代表著尖端運算技術與生物學研究的變革性融合，它從根本上重塑了製藥公司、生物技術公司和研究機構進行藥物研發、臨床試驗和患者照護的方式。這個充滿活力的市場涵蓋了機器學習演算法、自然語言處理、電腦視覺和預測分析等技術的應用，旨在加速基因組學、蛋白質組學、藥物研發和個人化醫療等領域的科學突破。

人工智慧技術正在革新傳統的生命科學研究方法，使研究人員能夠以前所未有的精確度和速度分析大量資料集、識別新的藥物標靶、最佳化臨床試驗調查方法並預測治療結果。生物數據的指數級成長、計算能力的不斷提升以及降低新治療方法上市時間和成本的迫切需求，共同推動了人工智慧在生命科學領域的應用。從分子化合物的虛擬篩檢到人工智慧驅動的診斷工具，再到機器人實驗室自動化，這些技術正在建構科學發現和醫療服務的新範式，並將人工智慧定位為現代生命科學生態系統創新不可或缺的催化劑。

市場動態

全球生命科學領域的人工智慧市場由幾個關鍵促進因素推動，這些因素正在從根本上改變產業格局。生物數據（包括基因組序列數據、臨床記錄和生物標記資訊）的指數級成長，催生了對能夠處理複雜資料集並從中提取有意義見解的先進人工智慧演算法的需求。傳統藥物研發流程成本不斷攀升且耗時過長（可能耗資超過26億美元，耗時10-15年），促使製藥公司採用人工智慧解決方案，以大幅縮短新療法上市的時間和降低財務負擔。此外，對個人化醫療和精準治療的日益重視，也催生了對能夠分析患者特定數據並最佳化治療通訊協定的人工智慧工具的巨大需求。

然而，該市場也面臨著許多限制，包括嚴格的法規結構要求在臨床應用前對人工智慧演算法進行廣泛的檢驗、與處理患者資訊相關的數據隱私問題，以及能夠有效彌合人工智慧技術與生命科學應用之間差距的熟練專業人員短缺。

此外，部署人工智慧基礎設施的高昂初始投資成本以及將人工智慧系統整合到現有實驗室和臨床工作流程中的難度，對規模較小的機構構成了重大障礙。儘管存在這些挑戰，但市場也蘊藏著巨大的機遇，這得益於創業投資對人工智慧驅動的生命科學Start-Ups的投資不斷增加、科技巨頭與製藥公司之間合作日益密切、人工智慧在醫學影像和病理學等領域的應用不斷擴展，以及雲端基礎人工智慧平台的加速普及——這些平台使各種規模的機構都能獲得先進的運算能力。

本報告的主要特點

• 本報告對全球生命科學領域的人工智慧市場進行了詳細分析，以 2024 年為基準年，對預測期（2025-2032 年）的市場規模和複合年成長率進行了預測。
• 它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
• 根據公司概況、產品系列、主要亮點、財務表現和策略等參數，對全球生命科學人工智慧市場的主要企業進行了分析。
• 本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
• 《全球生命科學人工智慧市場》報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過各種策略矩陣來分析全球生命科學人工智慧市場，從而更輕鬆地做出決策。

目錄

第1章 分析目標與先決條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監理及趨勢分析

• 市場動態
• 促進要素
• 抑制因素
• 機會
• 影響分析
• 重大進展
• 監管情景
• 產品上市/核准
• PEST分析
• 波特五力分析
• 企業合併情景
• 產業趨勢

4. 全球生命科學領域人工智慧市場（按產品/服務分類）（2020-2032 年）

• 介紹
• 軟體（演算法、人工智慧平台、模組等）
• 硬體（計算基礎設施、專用感測器、成像設備等）
• 服務（諮詢、整合、培訓、維護等）

5. 全球生命科學領域人工智慧市場以部署方式分類（2020-2032 年）

• 介紹
• 雲端基礎的
• 本地部署

6. 全球生命科學領域人工智慧市場分析方法（2020-2032 年）

• 介紹
• 說明/報告性
• 預測
• 指導性/決策支援
• 生成/合成數據/人工智慧驅動的分子生成

7. 全球生命科學領域人工智慧市場（按應用領域分類）（2020-2032 年）

• 介紹
• 藥物發現與開發
• 臨床試驗設計與最佳化
• 醫學診斷、影像診斷/生物標記檢測
• 精準醫療，個人化醫療
• 生物技術/生物製程/體學
• 病患監測，真實世界證據（RWE）
• 監管/安全和藥物警戒

8. 全球生命科學領域人工智慧市場（按最終用戶分類）（2020-2032 年）

• 介紹
• 製藥和生物技術公司
• 委外研發機構/臨床開發公司
• 醫療設備製造商
• 學術研究機構
• 醫療機構（醫院/診所）
• 監管機構和安全委員會

9. 全球生命科學領域人工智慧市場（實行技術分類）（2020-2032 年）

• 介紹
• 機器學習/統計模型
• 自然語言處理（NLP）/文字探勘
• 醫療設備製造商
• 電腦視覺/影像人工智慧
• 深度學習/神經網路
• 混合多模態人工智慧（模態融合）

10. 全球生命科學領域人工智慧市場按通路分類（2020-2032 年）

• 介紹
• 醫院藥房
• 零售藥房
• 網路藥房

第11章 全球生命科學領域人工智慧市場（按地區分類）（2020-2032 年）

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中非

第12章 競爭格局

• Insilico Medicine
• Atomwise
• Exscientia
• Schrodinger
• Recursion Pharmaceuticals
• BenevolentAI
• Cyclica
• Iktos
• Owkin
• Evogene
• Anima Biotech
• Generate Biomedicines
• Nimbus Therapeutics
• DeepMind/Isomorphic Labs
• IBM Watson Health

第13章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map (COM)

第14章 參考文獻與分析方法

• 參考
• 分析方法
• 關於 Coherent Market Insights

Artificial Intelligence in Life Science Market is estimated to be valued at USD 3.73 Bn in 2025 and is expected to reach USD 18.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.3% from 2025 to 2032.

The global artificial intelligence in life science market represents a transformative convergence of cutting-edge computational technologies and biological research, fundamentally reshaping how pharmaceutical companies, biotechnology firms, and research institutions approach drug discovery, clinical trials, and patient care. This dynamic market encompasses the application of machine learning algorithms, natural language processing, computer vision, and predictive analytics to accelerate scientific breakthroughs in areas such as genomics, proteomics, drug development, and personalized medicine.

AI technologies are revolutionizing traditional life science methodologies by enabling researchers to analyze vast datasets, identify novel drug targets, optimize clinical trial designs, and predict treatment outcomes with unprecedented accuracy and speed. The integration of AI in life sciences is driven by the exponential growth of biological data, increasing computational power, and the urgent need to reduce the time and cost associated with bringing new therapies to market. From virtual screening of molecular compounds to AI-powered diagnostic tools and robotic laboratory automation, these technologies are creating new paradigms for scientific discovery and healthcare delivery, positioning artificial intelligence as an indispensable catalyst for innovation in the modern life sciences ecosystem.

Market Dynamics

The global artificial intelligence in life science market is propelled by several key drivers that are fundamentally transforming the industry landscape. The exponential increase in biological data generation, including genomic sequencing data, clinical records, and biomarker information, necessitates sophisticated AI algorithms capable of processing and extracting meaningful insights from complex datasets. The rising costs and extended timelines associated with traditional drug development processes, which can exceed USD 2.6 billion and span 10-15 years, are driving pharmaceutical companies to adopt AI solutions that can significantly reduce both financial burden and time-to-market for new therapeutics. Additionally, the growing emphasis on personalized medicine and precision therapeutics is creating substantial demand for AI-powered tools that can analyze patient-specific data to optimize treatment protocols.

However, the market faces notable restraints including stringent regulatory frameworks that require extensive validation of AI algorithms before clinical implementation, data privacy concerns related to patient information handling, and the shortage of skilled professionals who can effectively bridge the gap between AI technology and life science applications.

Furthermore, the high initial investment costs for implementing AI infrastructure and the challenge of integrating AI systems with existing laboratory and clinical workflows present significant barriers for smaller organizations. Despite these challenges, the market presents tremendous opportunities driven by increasing venture capital investments in AI-driven life science startups, growing collaborations between technology giants and pharmaceutical companies, expanding applications in areas such as medical imaging and diagnostic pathology, and the accelerating adoption of cloud-based AI platforms that democratize access to advanced computational capabilities across organizations of all sizes.

Key Features of the Study

• This report provides in-depth analysis of the global artificial intelligence in life science market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global artificial intelligence in life science market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Insilico Medicine, Atomwise, Exscientia, Schrodinger, Recursion Pharmaceuticals, BenevolentAI, Cyclica, Iktos, Owkin, Evogene, Anima Biotech, Generate Biomedicines, Nimbus Therapeutics, DeepMind/Isomorphic Labs, and IBM Watson Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global artificial intelligence in life science market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in life science market

Market Segmentation

• Offering Insights (Revenue, USD Bn, 2020 - 2032)
  • Software (algorithms, AI-powered platforms, modules, etc.)
  • Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
  • Services (consulting, integration, training, maintenance, etc.)
• Deployment Model Insights (Revenue, USD Bn, 2020 - 2032)
  • Cloud Based
  • On-premise
• Analytics Insights (Revenue, USD Bn, 2020 - 2032)
  • Descriptive/Reporting
  • Predictive
  • Prescriptive/Decision support
  • Generative/Synthetic data/AI-driven molecule generation
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Drug Discovery and Development
  • Clinical Trials Design and Optimization
  • Medical Diagnosis and Imaging/Biomarker Detection
  • Precision and Personalized Medicine
  • Biotechnology/Bioprocessing/Omics
  • Patient Monitoring and Real-World Evidence (RWE)
  • Regulatory/Safety and Pharmacovigilance
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)/Clinical Research Firms
  • Medical Device Manufacturers
  • Academic and Research Institutions
  • Healthcare Providers (Hospitals/Diagnostic Clinics)
  • Regulatory Agencies and Safety Boards
• Enabling Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Machine Learning/Statistical Models
  • Natural Language Processing (NLP)/Text Mining
  • Computer Vision/Imaging AI
  • Deep Learning/Neural Networks
  • Hybrid and Multi-modal AI(fusion of modalities)
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Insilico Medicine
  • Atomwise
  • Exscientia
  • Schrodinger
  • Recursion Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Iktos
  • Owkin
  • Evogene
  • Anima Biotech
  • Generate Biomedicines
  • Nimbus Therapeutics
  • DeepMind/Isomorphic Labs
  • IBM Watson Health

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Artificial Intelligence in Life Science Market, By Offering
  • Global Artificial Intelligence in Life Science Market, By Deployment Model
  • Global Artificial Intelligence in Life Science Market, By Analytics
  • Global Artificial Intelligence in Life Science Market, By Application
  • Global Artificial Intelligence in Life Science Market, By End User
  • Global Artificial Intelligence in Life Science Market, By Enabling Technology
  • Global Artificial Intelligence in Life Science Market, By Distribution Channel
  • Global Artificial Intelligence in Life Science Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Artificial Intelligence in Life Science Market, By Offering, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Software (algorithms, AI-powered platforms, modules, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Services (consulting, integration, training, maintenance, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Intelligence in Life Science Market, By Deployment Model, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cloud Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• On-premise
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Intelligence in Life Science Market, By Analytics, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Descriptive/Reporting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Predictive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prescriptive/Decision support
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Generative/Synthetic data/AI-driven molecule generation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Intelligence in Life Science Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Trials Design and Optimization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Diagnosis and Imaging/Biomarker Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Precision and Personalized Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biotechnology/Bioprocessing/Omics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Patient Monitoring and Real-World Evidence (RWE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory/Safety and Pharmacovigilance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Intelligence in Life Science Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)/Clinical Research Firms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Healthcare Providers (Hospitals/Diagnostic Clinics)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory Agencies and Safety Boards
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Intelligence in Life Science Market, By Enabling Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Machine Learning/Statistical Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Natural Language Processing (NLP)/Text Mining
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Computer Vision/Imaging AI
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Deep Learning/Neural Networks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hybrid and Multi-modal AI(fusion of modalities)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Artificial Intelligence in Life Science Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Artificial Intelligence in Life Science Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive landscape

• Insilico Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Atomwise
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exscientia
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Schrodinger
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Recursion Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BenevolentAI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyclica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Iktos
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Owkin
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Evogene
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Anima Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Generate Biomedicines
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nimbus Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DeepMind/Isomorphic Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IBM Watson Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About Us